Loading
Search
▼ Nippon Life's Stable Business To Continue To Support Core Operating Profit
- Category:Other
The new-sales performance of Nippon Life Insurance Company (Nissay) is likely to be affected negatively over the near term by the COVID-19 pandemic and the low foreign interest rate environment, says AM Best.
Nevertheless, the global credit rating agency expects that the company’s stable in-force book of business will continue to support its core operating profit sustainably.
Indeed, Nissay’s operating performance has been strong and consistent, supported by a stable trend of premium income and core operating profit in the past. Annualised premiums from new policies declined over the first quarter of fiscal-year 2020 (April to June 2020), during which Japan declared a state of emergency, although this quickly recovered to 75% of the pre-pandemic level in the second quarter.
AM Best has affirmed Nissay's Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “aa-”. Concurrently, AM Best has affirmed the FSR of A- (Excellent) and the Long-Term ICR of “a-” of Nippon Life Insurance Company of America (dba Nippon Life Benefits or NLB) (West Des Moines, Iowa, USA). The outlook of these credit ratings is stable.
Balance sheet strength
The ratings of Nissay reflect its balance sheet strength, which AM Best categorises as strongest, as well as its strong operating performance, favourable business profile and appropriate enterprise risk management (ERM).
Nissay’s balance sheet strength assessment mainly reflects its risk-adjusted capitalisation at the strongest level, as measured by Best’s Capital Adequacy Ratio (BCAR). This assessment also is supported by the company’s low financial leverage, with an adjusted debt leverage ratio well below 25%.
In addition, its strong business network and good reputation as a life insurance company in Japan and overseas allow it to have good access to debt markets.
Business profile
Nissay is one of the leading life insurance companies in Japan, with a market share of 19% in terms of premium income. The company continues to have a strong sales representative base and is making efforts to diversify its distribution channels further to achieve greater revenue growth in its domestic market.
The company continues to be diversified modestly in terms of geography, given its relatively small operations in other Asia Pacific countries and the US.
The stable outlooks reflect AM Best’s expectation that Nissay will maintain its overall balance sheet assessment, supported by its risk-adjusted capitalisation at the strongest level, as measured by BCAR.
Ongoing strategic initiatives by management also are expected to ensure Nissay maintains a stable operating performance over the intermediate term.
Nevertheless, the global credit rating agency expects that the company’s stable in-force book of business will continue to support its core operating profit sustainably.
Indeed, Nissay’s operating performance has been strong and consistent, supported by a stable trend of premium income and core operating profit in the past. Annualised premiums from new policies declined over the first quarter of fiscal-year 2020 (April to June 2020), during which Japan declared a state of emergency, although this quickly recovered to 75% of the pre-pandemic level in the second quarter.
AM Best has affirmed Nissay's Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “aa-”. Concurrently, AM Best has affirmed the FSR of A- (Excellent) and the Long-Term ICR of “a-” of Nippon Life Insurance Company of America (dba Nippon Life Benefits or NLB) (West Des Moines, Iowa, USA). The outlook of these credit ratings is stable.
Balance sheet strength
The ratings of Nissay reflect its balance sheet strength, which AM Best categorises as strongest, as well as its strong operating performance, favourable business profile and appropriate enterprise risk management (ERM).
Nissay’s balance sheet strength assessment mainly reflects its risk-adjusted capitalisation at the strongest level, as measured by Best’s Capital Adequacy Ratio (BCAR). This assessment also is supported by the company’s low financial leverage, with an adjusted debt leverage ratio well below 25%.
In addition, its strong business network and good reputation as a life insurance company in Japan and overseas allow it to have good access to debt markets.
Business profile
Nissay is one of the leading life insurance companies in Japan, with a market share of 19% in terms of premium income. The company continues to have a strong sales representative base and is making efforts to diversify its distribution channels further to achieve greater revenue growth in its domestic market.
The company continues to be diversified modestly in terms of geography, given its relatively small operations in other Asia Pacific countries and the US.
The stable outlooks reflect AM Best’s expectation that Nissay will maintain its overall balance sheet assessment, supported by its risk-adjusted capitalisation at the strongest level, as measured by BCAR.
Ongoing strategic initiatives by management also are expected to ensure Nissay maintains a stable operating performance over the intermediate term.
- January 18, 2021
- Comment (1861)
- Trackback(0)
Comment(s) Write comment
baclofen tab [url=https://baclofen.guru/#]baclofen 10 mg no prescription [/url] what is the medicine baclofen for what does baclofen do to you?
-
buy quetiapine Web Site
- July 7, 2022
orlistat powder factory <a href="https://xenical.icu/#">xenical kopen zonder recept </a> is xenical a controlled substance how to use orlistat 120 mg
-
prednisone10 mg Web Site
- July 6, 2022
diflucan tabletas [url=http://diflucan.site/#]generic for diflucan [/url] can you take diflucan while on antibiotic how long does diflucan take to work
-
prednisone without rx Web Site
- July 6, 2022
-
AurlieplKt Web Site
- July 5, 2022
<a href="http://ivermectinetc.com/#">stromectol 3mg tablets</a>
-
rchwyars Web Site
- July 5, 2022
where to order cheap viagra <a href="https://gogiviagr.com/ ">sildenafil 55mg</a> https://gogiviagr.com/
-
Jnndgaima Web Site
- July 4, 2022
<a href="https://www.ivermectinoge.com/#">generic stromectol 6mg</a> buy ivermectin 12mg
-
tftjmuua Web Site
- July 4, 2022
most dangerous prescription drugs <a href="https://jijopharm.com/ ">canadian certified pharmacies</a> https://jijopharm.com/
-
Nbtsgaima Web Site
- July 4, 2022
how to get viagra uk <a href="https://gogiviagr.com/ ">buy viagra over the counter</a> https://gogiviagr.com/
-
Jnndgaima Web Site
- July 4, 2022
best viagra pills uk <a href="https://gogiviagr.com/ ">sildenafil 20 mg tablets coupon</a> https://gogiviagr.com/
-
Jnndgaima Web Site
- July 4, 2022
viagra cialis sample pack <a href="https://cheppercialis.com/ ">cialis with dapoxetine without prescription mastercard</a> https://cheppercialis.com/
-
WunbBries Web Site
- July 4, 2022
best female viagra tablet in india <a href="https://viagrexok.com/ ">viagra 50mg uk</a> https://viagrexok.com/
-
Ewbbsaisa Web Site
- July 4, 2022
cialis 20 mg price <a href="https://hojocialis.com/ ">cialis with dapoxetine</a> https://hojocialis.com/
-
JbqzNulajagma Web Site
- July 3, 2022
cheap cialis pills men <a href="https://hojocialis.com/ ">genereic cialis</a> https://hojocialis.com/
-
JbqzNulajagma Web Site
- July 3, 2022
cost of baricitinib Web Site- July 7, 2022